Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TAVR Versus SAVR in Young, Low-risk Patients
Author(s): Quynh Nguyen , Jessica GY Luc , Thomas E MacGillivray , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
Bicuspid Aortic Stenosis with and without Aortopathy: Considerations for Surgical Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement
Author(s): Arthur J Lee , Imran Baig , Katherine B Harrington , et al Added: 1 year ago

Intervention
PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk Patients
Author(s): David J Cohen Added: 2 years ago
Dr David J Cohen (St Francis Hospital, Roslyn, NY, US) discusses the findings from PARTNER 3 Economic Study. The study, presented first at TCT 2021, showed that for patients with severe AS and low surgical risk, TF-TAVR with the SAPIEN 3 valve is cost-saving compared with SAVR at 2-year follow-up. Discussion Points Importance of the Study Used Data Complexities in Relation to the Costs of… View more

Intervention
Who should be referred for TAVR
Author(s): Colin M Barker , Michael J Reardon Added: 3 years ago
Aortic stenosis (AS) has a long latent period and then rapid progression with high mortality once symptoms appear.1 The absence of an effective medical therapy for symptomatic severe AS led to a class I indication for aortic valve replacement (AVR) in both the US and European guidelines.2,3 Unfortunately, a study by Bach et al. in 2009 found that up to half of patients with symptomatic severe AS… View more

Vascular Disease and Surgery

Intervention
The Evolving Role of the Heart Team in Aortic Stenosis
Author(s): Sahoor Khan , William Shi , Tsuyoshi Kaneko , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
Research Area(s) / Expertise:

Inherited and Congenital Cardiac Conditions
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart… View more
ACC 2019: Corevalve low-risk TAVR Trial
Author(s): Nicolas M Van Mieghem , Michael J Reardon Added: 5 years ago
Prof Michael J Reardon (Houston Methodist, Texas, US) and Dr Nicolas van Mieghem (Rotterdam, NL) discuss the corevalve low-risk TAVR trial - self-expanding transcatheter or surgical aortic valve replacement in patients at low risk of surgical mortality. Filmed on site at ACC 2019 by Radcliffe Cardiology. Videography: Josh Birch Educational lead: Liam O'Neill (Chief Operating Officer) View more

Vascular Disease and Surgery
Managing Failed Transcatheter Aortic Valve Replacement
Author(s): Nils Perrin , Anita W Asgar Added: 2 years ago

Intervention
ACC.24: The DEDICATE Trial
Author(s): Moritz Seiffert Added: 1 week ago
ACC.24 — Investigator Dr Moritz Seiffert (University Heart and Vascular Center Hamburg, DE) joins us onsite at ACC to discuss the findings of the DEDICATE-DZHK6 Trial (NCT03112980).This randomized controlled, multi-center trial aimed to investigate whether transcatheter aortic valve implantation (TAVI) is non-inferior to surgical aortic valve replacement (SAVR) in patients with symptomatic severe… View more

Intervention
View from the Thoraxcenter: What's Hot at ACC.24?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 3 weeks ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more

Anticoagulation

Heart Failure